Celularity
celularity.com
Actively hiring
Regenerative Medicine
Cell & Gene Therapy
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
News
Celularity Director Philip Barach Updates Convertible Notes and Warrants, Acquires New Securities
Read more
Report
Celularity Closes Over $10 Mln Initial Financing; Targets Positive Operating Cash Flow By Q1 2027
Celularity (CELU) closed an initial financing generating over $10 million in gross proceeds as part of a recapitalization plan of up to $28 million. The company has cut monthly cash burn by more than $1 million and expects positive monthly operating cash
Read more
Report
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
Plan combines up to $25 million in new capital with restructuring of $3 million in existing debt to support commercial execution and manufacturing...
Read more
Report
Celularity and MuseCell Innovations Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell Platform
Collaboration is intended to expand U.S. manufacturing of Dezawa MuseCells initially across qualified perinatal sources using the licensed Dezawa Method and manufacturing of DMC derived products, including Dezawa MuseExosomes and Dezawa MuseSecretome FLOR
Read more
Report
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
FLORHAM PARK, N.J. and ORLANDO, Fla., June 04, 2026 (GLOBE NEWSWIRE) - Celularity Inc. (Nasdaq: CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular therapies, and Fountain Life Managem
Read more
Report
Celularity Releases CEO Letter to Shareholders
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) - Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular therapies, today announced that it ha
Read more
Report
Celularity Releases CEO Letter to Shareholders
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (
Read more
Report
Celularity Appoints Rick Gonzalez as Chief Commercial Officer
Appointment supports Celularity's focus on longevity, regenerative medicine and preservation of human performance by advancing commercialization of cenplacel-L and Lifebank FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) - Celularity Inc. (Nasdaq: CELU
Read more
Report
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
Company advances focused strategy, strengthens balance sheet and positions business for long-term growth FLORHAM PARK, N.J., May 01, 2026 (GLOBE NEWSWIRE) - Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative a
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Celularity over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
43/100
Developer tools
Microsoft Excel
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$138k
Typical range
$135k – $140k
Open positions
2
2
Jobs
Senior
50%
Staff
50%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 1 | $140k | $140k |
| Staff | 1 | $135k | $135k |
Highest paying role
Facilities Maintenance Specialist
$140k
Normalized to USD per year
People
Mohit Bhatia
Executive Officer
John Haines
Executive Officer
Robert Hariri
Executive Officer, Director
Curtis Quigley
Executive Officer
Timothy Smith
Executive Officer
Beth Steinbrenner
Executive Officer
Andrew Pecora
Executive Officer
Henry Brock
Executive Officer
William Waller
Executive Officer
Joseph Kaminski
Executive Officer
Carlos Ramirez
Executive Officer
Gertjan Bartlema
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
58/100
Growing
Open positions
2
2 opened / 2 closed in 30 days
Median time-to-fill
10 days
faster than 67% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Field & Service
50% ▲
Finance
25% ▲
Customer Success
25% ▲
Activity Timeline
Added Outlook to stack
Oct 2026
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
1
Busiest office
Florham Park
Warren
United States
HQ
Florham Park
United States
2 open roles 4 posted in 90 days $138k Avg Salary
hires for Finance, Field & Service
Financials
Total raised
$157.5M
Latest round
Venture - Series Unknown
Funding rounds
6